实用临床医药杂志
實用臨床醫藥雜誌
실용림상의약잡지
JOURNAL OF JIANGSU CLINICAL MEDICINE
2014年
5期
96-98
,共3页
于开军%李炳东%李国萍%刘晓波%庞素媛
于開軍%李炳東%李國萍%劉曉波%龐素媛
우개군%리병동%리국평%류효파%방소원
西酞普兰%功能性消化不良%情绪障碍%疗效
西酞普蘭%功能性消化不良%情緒障礙%療效
서태보란%공능성소화불량%정서장애%료효
citalopram%functional dyspepsia%emotional disorder%efficiency
目的:观察西酞普兰对功能性消化不良(FD)患者焦虑、抑郁症状的影响。方法将132例 FD 患者随机分为治疗组68例和对照组64例,对照组给予奥美拉唑与莫沙必利,治疗组在此基础上,加用抗抑郁剂西酞普兰,并给予相应心理指导。分别采用抑郁自评量表(SDS)及焦虑自评量表(SAS)对抑郁、焦虑障碍进行评定,观察2组治疗前及治疗第2、4、8周 FD症状积分的变化、临床疗效及不良反应发生情况。结果132例患者中,60例发生抑郁障碍,53例发生焦虑障碍;治疗第2、4、8周,治疗组 SDS 及 SAS 标准分均显著低于对照组,且治疗第4、8周,FD 症状积分明显低于对照组,而总有效率明显高于对照组,差异均有统计学意义。2组治疗前后均未见明显异常现象。结论 FD 患者普遍存在焦虑、抑郁情绪,而在常规治疗基础上加用西酞普兰可显著改善患者抑郁、焦虑障碍,缓解症状,疗效显著,且不良反应少。
目的:觀察西酞普蘭對功能性消化不良(FD)患者焦慮、抑鬱癥狀的影響。方法將132例 FD 患者隨機分為治療組68例和對照組64例,對照組給予奧美拉唑與莫沙必利,治療組在此基礎上,加用抗抑鬱劑西酞普蘭,併給予相應心理指導。分彆採用抑鬱自評量錶(SDS)及焦慮自評量錶(SAS)對抑鬱、焦慮障礙進行評定,觀察2組治療前及治療第2、4、8週 FD癥狀積分的變化、臨床療效及不良反應髮生情況。結果132例患者中,60例髮生抑鬱障礙,53例髮生焦慮障礙;治療第2、4、8週,治療組 SDS 及 SAS 標準分均顯著低于對照組,且治療第4、8週,FD 癥狀積分明顯低于對照組,而總有效率明顯高于對照組,差異均有統計學意義。2組治療前後均未見明顯異常現象。結論 FD 患者普遍存在焦慮、抑鬱情緒,而在常規治療基礎上加用西酞普蘭可顯著改善患者抑鬱、焦慮障礙,緩解癥狀,療效顯著,且不良反應少。
목적:관찰서태보란대공능성소화불량(FD)환자초필、억욱증상적영향。방법장132례 FD 환자수궤분위치료조68례화대조조64례,대조조급여오미랍서여막사필리,치료조재차기출상,가용항억욱제서태보란,병급여상응심리지도。분별채용억욱자평량표(SDS)급초필자평량표(SAS)대억욱、초필장애진행평정,관찰2조치료전급치료제2、4、8주 FD증상적분적변화、림상료효급불량반응발생정황。결과132례환자중,60례발생억욱장애,53례발생초필장애;치료제2、4、8주,치료조 SDS 급 SAS 표준분균현저저우대조조,차치료제4、8주,FD 증상적분명현저우대조조,이총유효솔명현고우대조조,차이균유통계학의의。2조치료전후균미견명현이상현상。결론 FD 환자보편존재초필、억욱정서,이재상규치료기출상가용서태보란가현저개선환자억욱、초필장애,완해증상,료효현저,차불량반응소。
Objective To observe the influence of citalopram on anxiety and depression of patient with functional dyspepsia (FD).Methods One hundred and thirty-two FD patients were randomly divided into treatment group (n =68)and control group (n =64).The patients in con-trol group were given omeprazole and mosapride,while the patients in the treatment group were added citalopram based on the treatment in the control group,and meanwhile given corresponding psychology guidance.The anxiety and depression disorders were evaluated respectively by Self-rat-ing Depression Scale (SDS)and Self-rating Anxiety Scale (SAS).The symptomatic scores before treatment and on the second,fourth and eighth week of treatment,clinical efficiency and adverse reactions were observed in the two groups.Results Among 132 patients,there were 60 with de-pression and 53 patients suffering from anxiety.SDS and SAS scores on on the second,fourth and eighth week of treatment and FD symptomatic scores on the fourth and eighth weeks of treatment were obviously lower,while the overall response rate was significantly higher in treatment group than that in the control group.So the difference was statistical significant.Before and after treat-ment,there were no abnormal patients in two groups.Conclusion FD patients are usually accom-panied by anxiety and depression.The application of citalopram on the basis of routine treatment could significantly ameliorate the patients′anxiety and depression,alleviate symptoms,improve the efficiency and reduce adverse reactions.